Efficacy and Safety of PRO-148 Ophthalmic Solution Versus SYSTANE® in the Treatment of Patients With Dry Eye Syndrome
Condition(s):Dry Eye SyndromeLast Updated:October 30, 2018Completed
Hide Studies Not Open or Pending
Condition(s):Dry Eye SyndromeLast Updated:October 30, 2018Completed
Condition(s):Healthy VolunteersLast Updated:March 11, 2020Completed
Condition(s):Crohn’s DiseaseLast Updated:August 1, 2019Completed
Condition(s):Esophageal CancerLast Updated:April 7, 2017Terminated
Condition(s):Acute Coronary Syndromes; Stable Angina PectorisLast Updated:February 4, 2015Completed
Condition(s):HIV InfectionsLast Updated:August 4, 2008Completed
Condition(s):Bacterial VaginosesLast Updated:April 28, 2021Unknown status
Condition(s):Dry Eye Syndromes; Keratoconjunctivitis Sicca; Lacrimal Apparatus Diseases; Keratoconjunctivitis; Eye Diseases; Keratitis; Corneal Disease; Ophthalmic SolutionLast Updated:May 23, 2019Completed
Condition(s):Pediatric Functional ConstipationLast Updated:March 28, 2023Recruiting
Condition(s):Anemia; Inflammation; MalnutritionLast Updated:September 5, 2014Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.